跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEPHALEXIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CEPHALEXIN
Authorized
STANDARD
CEPHALEXIN
sivem pharmaceuticals ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ee08bb0344551450
Company
sivem pharmaceuticals ulc
Type
Standard
Approval Details
Approval Id
ee08bb0344551450
Drug Approval Canada Name
CEPHALEXIN
Product Name
CEPHALEXIN
Status
Marketed
Status Date
2020-10-22
Original Market Date
2020-10-22
Din
02495651
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.06.04
Atc Original
J01DB01 CEFALEXIN
Atc Name
j 01 db 01
Aig Number
0105911003
Company Name
sivem pharmaceuticals ulc
Company Address
4705 Dobrin Street, Saint-Laurent, Quebec, Canada, H4R 2P7
Active Ingredients
CEPHALEXIN (CEPHALEXIN MONOHYDRATE)
500 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ee08bb0344551450
Type
Standard
Back to Health Canada Approvals